Highlights and Quick Summary
- EBITDA Margin for the quarter ending September 30, 2022 was 67.81% (a 15.6% increase compared to previous quarter)
- Year-over-year quarterly EBITDA Margin decreased by -181.27%
- Annual EBITDA Margin for 2021 was -113.81% (a -43.97% decrease from previous year)
- Annual EBITDA Margin for 2020 was -203.13% (a -79.68% decrease from previous year)
- Twelve month EBITDA Margin ending September 30, 2022 was 44.51% (a 91.19% increase compared to previous quarter)
- Twelve month trailing EBITDA Margin decreased by -165.7% year-over-year
Trailing EBITDA Margin for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| 44.51% | 23.28% | -8.68% | -67.75% |
Visit stockrow.com/BBLN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EBITDA Margin of Babylon Holdings Limited
Most recent EBITDA Marginof BBLN including historical data for past 10 years.Interactive Chart of EBITDA Margin of Babylon Holdings Limited
Babylon Holdings Limited EBITDA Margin for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | 67.81% | 58.66% | 62.64% | – |
| 2021 | -83.44% | -72.09% | -101.48% | -9.68% | -113.81% |
| 2020 | – | – | – | 0.0% | -203.13% |
| 2019 | – | – | – | – | -999.9% |
Business Profile of Babylon Holdings Limited
Sector: Healthcare
Industry: Health Information Services